Uzansertib
Uzansertib (INCB053914) is an orally active, ATP-competitive pan-PIM kinase inhibitor with IC50s of 0.24 nM, 30 nM, 0.12 nM for PIM1, PIM2, PIM3, respectively. Uzansertib has broad anti-proliferative activity against a variety of hematologic tumor cell lines[1].
Product Specifications
CAS Number
1620012-39-6
Product Name Alternative
INCB053914
UNSPSC
12352005
Target
Pim
Type
Reference compound
Related Pathways
JAK/STAT Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/uzansertib.html
Purity
99.45
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=CN=C4C(CC[C@H]4O)=C3N5C[C@@H](N)[C@H](O)[C@@H](C)C5
Molecular Formula
C26H26F3N5O3
Molecular Weight
513.51
References & Citations
[1]Koblish H, et al. Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies. PLoS One. 2018 Jun 21;13 (6) :e0199108.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
PIM1; PIM2; PIM3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Ly2180-1mgEcoli 1 mg (E. coli)
Recombinant Campylobacter Jejuni hslV Protein (aa 1-180) (strain 81116 / NCTC 11828)
Sign In for Pricing
View Details 
A300-949A-T 2 µg
Rabbit anti-Topo Il Beta Antibody, Affinity Purified
Sign In for Pricing
View Details 
MBS6359698-01 0.2 mL
TSPYL4, CT (TSPYL4, KIAA0721, Testis-specific Y-encoded-like protein 4) (Azide free) (HRP)
Sign In for Pricing
View Details